A former chief financial officer of a New Jersey biotechnology company has been indicted for insider trading after allegedly giving his girlfriend nonpublic information about clinical trial results for a new breast cancer drug.
the staff of the Ridgewood blog
Newark NJ, the former chief financial officer for a biopharmaceutical company was indicted today for his role in an insider trading scheme, U.S. Attorney Philip R. Sellinger announced.
Continue reading New Jersey-based Biopharmaceutical Company CFO Indicted For Insider Trading
